related words |
arcalyst |
sanctura |
abthrax |
carcinogenicity |
levoleucovorin |
advexin |
analyzer |
finishing |
medimmune |
ipilimumab |
synthesis |
bioequivalence |
neuropathic |
apap |
preapproval |
pediatric |
biosensors |
outlicensing |
norcross |
ppi |
|
related documents |
1022974--3/31/2009--DECODE_GENETICS_INC |
1022974--3/17/2008--DECODE_GENETICS_INC |
|
related topics |
{product, candidate, development} |
{debt, indebtedness, cash} |
{product, liability, claim} |
{cost, contract, operation} |
{control, financial, internal} |
{cost, operation, labor} |
{stock, price, share} |
{loan, real, estate} |
{property, intellectual, protect} |
{gas, price, oil} |
{interest, director, officer} |
{competitive, industry, competition} |
{acquisition, growth, future} |
{personnel, key, retain} |
{provision, law, control} |
{product, market, service} |
{operation, international, foreign} |
{tax, income, asset} |
{regulation, government, change} |
{cost, regulation, environmental} |
|